About

The EvokedRx™ technology was conceived to advance the treatment of Diabetic Peripheral Neuropathy (DPN) by addressing pain, sensation loss, and balance issues caused by the condition, while enabling remote disease monitoring. Our proprietary electrical Duplet Cathodes Therapy (DCT™), non-invasive electrode arrays, and evoked-response sensing technology show great promise for targeted pain relief, improved sensation, and enhanced balance, with the potential to revolutionize remote monitoring. Although our technology is still in development and no medical products have yet been cleared for commercialization, we are dedicated to advancing scientific innovation to deliver effective, non-invasive solutions that could significantly improve the lives of those affected by this debilitating condition